← Back to Search

Stent

Venous Stent Arm for Deep Vein Thrombosis

N/A
Waitlist Available
Led By Dr. Lawrence (Rusty) Hofmann MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights

Summary

To study the safety and efficacy of drug coated stents for the treatment of venous occlusions and stenoses in the lower extremity. The use of the device for the treatment of peripheral arterial disease is approved by the FDA, however, the use of the device in venous occlusions and stenoses, although performed by some practitioners, has not yet been studied in detail.

Eligible Conditions
  • Deep Vein Thrombosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Primary Patency Rate
Stent, device
Secondary outcome measures
Adverse Events
Assisted-primary Patency
Decrease in Swelling of Affected Extremity
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Venous Stent ArmExperimental Treatment1 Intervention
The study is a single treatment arm study and the venous stent will be placed in all eligible participants.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,448 Previous Clinical Trials
17,492,393 Total Patients Enrolled
3 Trials studying Deep Vein Thrombosis
295 Patients Enrolled for Deep Vein Thrombosis
Dr. Lawrence (Rusty) Hofmann MDPrincipal InvestigatorStanford University
~0 spots leftby Sep 2025